On one hand, since AI is somewhat data-driven, this may be due to differences in sample size, as the sample size of HER2-enriched and TN subgroups are relatively small because of the lower frequency of these types of breast cancer in clinical reality. The gene discussed is ERBB2; the disease is breast cancer.